eMedicine Specialties > Infectious Diseases > Viral Infections

Smallpox: Differential Diagnoses & Workup

Author: Aneela Naureen Hussain, MD, FAAFM, Assistant Professor, Department of Family Medicine, State University of New York Downstate Medical Center; Consulting Staff, Department of Family Medicine, University Hospital of Brooklyn
Coauthor(s): Fazal Hussain, MD, MBBS, Director, Clinical Research, King Faisal Cancer Centre; Maqsood Alam, MD, Fellow, Department of Infectious Diseases, State University of New York Downstate Medical Center; Dennis J Cleri, MD, FACP, FAAM, FIDSA, Chairman, Graduate Medical Education Committee, Professor of Medicine, Associate Professor of Infection Disease, Seton Hall University; Director, Internal Medicine Residency Program, St Francis Medical Center
Contributor Information and Disclosures

Updated: Oct 20, 2008

Differential Diagnoses

Enteroviruses
Meningococcemia
Erythema Multiforme (Stevens-Johnson Syndrome)
Molluscum Contagiosum
Herpes Simplex
Poxviruses
Herpes Zoster
Rickettsialpox
Impetigo
Rocky Mountain Spotted Fever
Influenza
Syphilis
Malaria
Vaccinia
Meningitis
Varicella-Zoster Virus

Other Problems to Be Considered

Monkeypox
Acne
Chickenpox (varicella-zoster virus)
Drug eruptions
Generalized vaccinia and eczema vaccinatum
Insect bites
Viral hemorrhagic fevers (may be confused with hemorrhagic smallpox)

Workup

Laboratory Studies

  • Smallpox infection may be confirmed based on the presence of brick-shaped virions viewed with electron microscopy examination of vesicular or pustular fluid or scabs.
    • Although smallpox and all other viruses in the Orthopoxvirus genus exhibit identically appearing brick-shaped virions, the clinical aspects of these diseases generally suffice for distinguishing cowpox and vaccinia from smallpox.
    • Monkeypox virions may also be indistinguishable from smallpox virions, but naturally occurring monkeypox is typically limited to tropical rain forest areas of Africa.
  • Variola virus can be detected with electron microscopy, virus culture from live cells, or DNA analysis using polymerase chain reaction (PCR).1,2
    • Cell culture is seldom used because it is not as effective as the other methods and because it requires the use of live virus, which, in turn, requires the use of a biosafety level 4 (BSL-4) laboratory.
    • PCR and electron microscopy can be used to examine inactivated samples and therefore do not require such high levels of isolation and can be performed in local laboratories.
    • Electron microscopy can help identify the virus as a member of the Orthopoxvirus genus, but it cannot help determine the exact species.
    • PCR can be used to identify the species (variola) and can even distinguish minor genetic variations in the different strains. PCR is a relatively new technology and has been used to identify variola only twice previously, and never in a clinical situation. PCR can amplify small and specific lengths of DNA and can accurately differentiate variola virus DNA from other species in the genus. The sensitivity is 5-10 copies of DNA. PCR can be useful to distinguish between chickenpox and smallpox.
  • Smallpox skin specimen should be collected with precautions in place.
    • Gloves should be worn during collection. Fluid from lesions can be harvested on a cotton swab; prior to shipping specimens, state and local health department laboratories should be contacted for specific instructions.
    • The CDC recommends the following procedures for handling specimens obtained from a patient thought to be infected with the smallpox virus:
      • Specimens should be collected by someone who has recently been vaccinated (or who is vaccinated that day) and who wears gloves and a mask.
      • To obtain vesicular or pustular fluid, the lesions may need to be opened with the blunt edge of a scalpel. The fluid can then be harvested on a cotton swab. Scabs can be picked off with forceps.
      • Specimens should be deposited in a Vacutainer tube. The tube should be sealed with adhesive tape at the juncture of the stopper and the tube. This tube, in turn, should be enclosed in a second durable and watertight container.
      • State or local health department laboratories should be contacted immediately for proper specimen shipping protocols.
  • Laboratory examination should be performed only in designated BSL-4 laboratories. Once established that an epidemic is caused by the smallpox virus, clinically similar cases would not require further laboratory testing.

More on Smallpox

Overview: Smallpox
Differential Diagnoses & Workup: Smallpox
Treatment & Medication: Smallpox
Follow-up: Smallpox
Multimedia: Smallpox
References

References

  1. Espy MJ, Cockerill III FR, Meyer RF, et al. Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol. Jun 2002;40(6):1985-8. [Medline].

  2. Ropp SL, Jin Q, Knight JC, et al. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J Clin Microbiol. Aug 1995;33(8):2069-76. [Medline].

  3. Bray M, Martinez M, Smee DF, et al. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis. Jan 2000;181(1):10-9. [Medline].

  4. De Clercq E. Cidofovir in the treatment of poxvirus infections. Antiviral Res. Jul 2002;55(1):1-13. [Medline].

  5. Smee DF, Bailey KW, Sidwell RW. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antivir Chem Chemother. Jan 2001;12(1):71-6. [Medline].

  6. Smee DF, Bailey KW, Wong MH, et al. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res. Oct 2001;52(1):55-62. [Medline].

  7. Alibek K, Handelman S. Biohazard. In: The Chilling True Story of the Largest Covert Biological Weapons Program in the World - Told from Inside by the Man Who Ran It. New York, NY: Random House; 1999.

  8. ARF BM, Moyer RW. Entomopoxvirus B. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:914-8.

  9. Aylward B, Hennessey KA, Zagaria N, Olivé JM, Cochi S. When is a disease eradicable? 100 years of lessons learned. Am J Public Health. Oct 2000;90(10):1515-20. [Medline].

  10. Bergoin M. Entomopoxvirus A. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:911-3.

  11. Brauner SC, Pavan-Langston D. Smallpox, vaccinia, and the eye. Int Ophthalmol Clin. Spring 2006;46(2):11-25. [Medline].

  12. Breman JG, Arita I, Fenner F. Preventing the return of smallpox. N Engl J Med. Jan 30 2003;348(5):463-6. [Medline].

  13. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. Apr 25 2002;346(17):1300-8. [Medline].

  14. Bugert JJ, Melquiot N. Molluscipoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:880-4.

  15. Centers for Disease Control and Prevention. Emergency Preparedness and Response. Smallpox. Available at: http://www.bt.cdc.gov/agent/smallpox/index.asp. Atlanta, Ga: Centers for Disease Control and Prevenion; 2004:[Full Text].

  16. Centers for Disease Control and Prevention (2002). Smallpox vaccine overview. Available at: http://www.bt.cdc.gov/agent/smallpox/vaccination/facts.asp. [Full Text].

  17. Centers for Disease Control and Prevention, National Immunization Program. Smallpox: What Every Clinician Should Know [video online]. Available at: http://www.cdc.gov/nip/ed/smallpox-trg/clinician-should-know/default.htm. Atlanta, Ga: Centers for Disease Control and Prevention;. Apr 2003;[Full Text].

  18. Cleri DJ, Porwancher RB, Ricketti AJ, et al. Smallpox as a bioterrorist weapon: myth or menace?. Infect Dis Clin North Am. Jun 2006;20(2):329-57, ix. [Medline].

  19. Cleri DJ, Ricketti AJ, Villota FJ, et al. Smallpox, monkeypox, other pox diseases and vaccination. Infect Dis Pract Clin. 2005;29:396-406.

  20. Cleri DJ, Villota FJ, Porwancher RB. Smallpox, bioterrorism, and the neurologist. Arch Neurol. Apr 2003;60(4):489-94. [Medline].

  21. Department of Defense. MILVAX. Department of Defense Smallpox Vaccination Program. Available at: http://smallpox.mil/. Arlington, Va: Department of Defense; 2004[Full Text].

  22. Eichner M. Case isolation and contact tracing can prevent the spread of smallpox. Am J Epidemiol. Jul 15 2003;158(2):118-28. [Medline].

  23. Essani K, Bejcek BE, Paulose M. Yatapoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:907-10.

  24. Federici BA. Entomopoxvirus C. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:919-21.

  25. Fenner F, Henderson DA, Arita I, et al. Smallpox and Its Eradication. In: Communicable Disease Surveillance and Response. Available at: http://www.who.int/emc/diseases/smallpox/Smallpoxeradication.html. Geneva, Switzerland: on: World Health Organizati; 1988:1460. [Full Text].

  26. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med. Apr 25 2002;346(17):1275-80. [Medline].

  27. Greenberg RN, Kennedy JS. ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. Expert Opin Investig Drugs. Apr 2008;17(4):555-64. [Medline].

  28. Greenberg RN, Kennedy JS. ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. Expert Opin Investig Drugs. Apr 2008;17(4):555-64. [Medline].

  29. Gross CP, Sepkowitz KA. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered. Int J Infect Dis. Jul-Sep 1998;3(1):54-60. [Medline].

  30. Henderson DA. The looming threat of bioterrorism. Science. Feb 26 1999;283(5406):1279-82. [Medline].

  31. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. Jun 9 1999;281(22):2127-37. [Medline].

  32. Immunization Practices Advisory Committee (ACIP). Vaccinia (smallpox) vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. Dec 13 1991;40:1-10. [Medline].

  33. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. May 12 1999;281(18):1735-45. [Medline].

  34. Johnson RT. Postinfectious demyelinated diseases. In: Viral Infection of the Nervous System. Williams & Wilkins; 1981:765-73.

  35. Kerr PJ, McFadden G. Leporipoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:873-9.

  36. Kitching RP. Capripoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:869-72.

  37. Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am. May 2008;26(2):517-47, x-xi. [Medline].

  38. Lawler JV, Burgess TH. Smallpox. In: Roy MJ, ed. Physician's Guide To Terrorist Attack. Totowa, NJ: Humana Press; 2003:197-220.

  39. LeDuc JW, Jahrling PB. Strengthening national preparedness for smallpox: an update. Emerg Infect Dis. Jan-Feb 2001;7(1):155-7. [Medline].

  40. Letai AG. Smallpox and smallpox vaccination. N Engl J Med. May 8 2003;348(19):1920-5; author reply 1920-5. [Medline].

  41. Meltzer MI, Damon I, LeDuc JW, et al. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis. Nov-Dec 2001;7(6):959-69. [Medline].

  42. Mercer A, Fleming S. Parapoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:896-901.

  43. Moss B, Senkevich TG. Orthopoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:885-95.

  44. Neff J, Modlin J, Birkhead GS, et al. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. Clin Infect Dis. Mar 15 2008;46 Suppl 3:S258-70. [Medline].

  45. Ness TL, Moyer RW. Suipoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:902-6.

  46. Preston R. The Demon in the Freezer: A True Story. New York, NY: Random House; 2002.

  47. Redfield RR, Wright DC, James WD, et al. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med. Mar 12 1987;316(11):673-6. [Medline].

  48. Reeder MM, Palmer PES. Smallpox osteomyelitis (osteomyelitis variolosa). In: The Radiology of Tropical Medicine With Epidemiological, Pathological and Clinical Correlation. Baltimore: Williams & Wilkins; 1981:765-73.

  49. Ropp SL, Esposito JJ, Loparev VN, Palumbo GJ. Poxviruses infecting humans. In: Murray PR, ed. Manual of Clinical Microbiology. Washington, DC: American Society of Microbiology; 1999:1137-44.

  50. Ryabchikova E, Sokunova E, Kononova J, Guskov A. Studies of Variola Virus Replication in Cell Cultures and Chick Embryo Chorion-allantois Membrane. In: Price R, ed. ASA Newsletter. Available at: http://www.asanltr.com/newsletter/02-3/articles/023a.htm. Aberdeen, Md: Applied Science and Analysis; 2002:Article 023a. [Full Text].

  51. Ryan MA, Seward JF. Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006. Clin Infect Dis. Mar 15 2008;46 Suppl 3:S221-6. [Medline].

  52. Skinner MA, Laidlaw SM, Boulanger D. Avipoxvirus. In: Tidona CA, Darai G, eds. The Springer Index of Viruses. Berlin: Springer-Verlag; 2002:864-8.

  53. Stearn EW, Stearn AE. The Effect of Smallpox on the Destiny of the Amerindian. Boston, Mass: Bruce Humphries; 1945.

  54. Strikas RA, Neff LJ, Rotz L, et al. US Civilian Smallpox Preparedness and Response Program, 2003. Clin Infect Dis. Mar 15 2008;46 Suppl 3:S157-67. [Medline].

  55. Torres Cantero AM. Is smallpox "in" again?. J Epidemiol Community Health. Apr 2004;58(4):279. [Medline].

  56. Tudor V, Strati I. The clinical picture. In: Smallpox: Cholera. Tunbridge Wells, Kent: Abacus Press; 1977:34-71.

  57. U.S. Bureau of the Census. Statistical Abstract of the United States: 1999. 119th ed. Washington, DC: Bureau of the Census; 1999.

  58. US Army Center for Health Promotion and Preventive Medicine. Current issues in Smallpox. Available at: http://chppm-www.apgea.army.mil/risk/current.aspx. [Full Text].

  59. US Army Medical Research Institute of Infectious Diseases. Smallpox. In: Kortpeter M, Christopher G, Cieslak T, et al, eds. USAMRIID's Medical Management of Biological Casualties. Available at: http://www.usamriid.army.mil/education/bluebook.html. 4th ed. Fort Detrick, Md: Operational Medicine Department; 2001:44-8. [Full Text].

  60. Wells TS, LeardMann CA, Smith TC, et al. Self-reported adverse health events following smallpox vaccination in a large prospective study of US military service members. Hum Vaccin. Mar-Apr 2008;4(2):127-33. [Medline].

  61. World Health Organization. WHO Fact Sheet on Smallpox. In: Communicable Disease Surveillance and Response. Available at: http://www.who.int/emc/diseases/smallpox/factsheet.html. Geneva, Switzerland: Oct 2001:[Full Text].

Further Reading

Keywords

smallpox, Poxvirus variolae, variola virus, variola, variola vera, variola major, variola minor, orthopoxvirus, poxvirus, hemorrhagic smallpox, ordinary smallpox, flat smallpox, modified smallpox, alastrim, amass, cottonpox, milkpox, whitepox, Cuban itch, Kaffir, biological agent, bioterrorism, bio-terrorism, biological attack, pox virus, malignant smallpox, fulminant smallpox, variola sine eruptione, variola sine exanthemata, smallpox vaccination, vaccinia immune globulin, vaccinia immunoglobulin, VIG, VIGIV, osteomyelitis variolosa, variola residua, fetal vaccinia

Contributor Information and Disclosures

Author

Aneela Naureen Hussain, MD, FAAFM, Assistant Professor, Department of Family Medicine, State University of New York Downstate Medical Center; Consulting Staff, Department of Family Medicine, University Hospital of Brooklyn
Aneela Naureen Hussain, MD, FAAFM is a member of the following medical societies: American Academy of Family Physicians, American Medical Association, American Medical Women's Association, Medical Society of the State of New York, and Society of Teachers of Family Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Fazal Hussain, MD, MBBS, Director, Clinical Research, King Faisal Cancer Centre
Fazal Hussain, MD, MBBS is a member of the following medical societies: American College of Radiology
Disclosure: Nothing to disclose.

Maqsood Alam, MD, Fellow, Department of Infectious Diseases, State University of New York Downstate Medical Center
Maqsood Alam, MD is a member of the following medical societies: American Medical Association and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Dennis J Cleri, MD, FACP, FAAM, FIDSA, Chairman, Graduate Medical Education Committee, Professor of Medicine, Associate Professor of Infection Disease, Seton Hall University; Director, Internal Medicine Residency Program, St Francis Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Duane R Hospenthal, MD, PhD, Chief, Infectious Disease Service, San Antonio Military Medical Center, Brooke Army Medical Center; Professor of Medicine, Uniformed Services University of the Health Sciences
Duane R Hospenthal, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Society for Infectious Diseases, International Society of Travel Medicine, and Medical Mycology Society of the Americas
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

John L Brusch, MD, FACP, Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance
John L Brusch, MD, FACP is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.